Article info
Brief communication
Lung-targeting lentiviral vector for passive immunisation against influenza
- Correspondence to Dr Stephen C Hyde, Gene Medicine Research Group, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK; steve.hyde{at}ndcls.ox.ac.uk
Citation
Lung-targeting lentiviral vector for passive immunisation against influenza
Publication history
- Received February 12, 2020
- Revised June 12, 2020
- Accepted July 30, 2020
- First published September 3, 2020.
Online issue publication
November 16, 2020
Article Versions
- Previous version (3 September 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.